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Abstract: Dental pulp tissue supports the vitality of the tooth, but it is particularly  
vulnerable to external insults, such as mechanical trauma, chemical irritation or microbial 
invasion, which can lead to tissue necrosis. In the present work, we present an endodontic 
regeneration method based on the use of a tridimensional (3D) hyaluronan scaffold and 
human dental pulp stem cells (DPSCs) to produce a functional dental pulp-like tissue  
in vitro. An enriched population of DPSCs was seeded onto hyaluronan-based non-woven 
meshes in the presence of differentiation factors to induce the commitment of stem cells  
to neuronal, glial, endothelial and osteogenic phenotypes. In vitro experiments, among 
which were gene expression profiling and immunofluorescence (IF) staining, proved  
the commitment of DPSCs to the main components of dental pulp tissue. In particular,  
the hyaluronan-DPSCs construct showed a dental pulp-like morphology consisting of 
several specialized cells growing inside the hyaluronan fibers. Furthermore, these 
constructs were implanted into rat calvarial critical-size defects. Histological analyses and 
gene expression profiling performed on hyaluronan-DPSCs grafts showed the regeneration 
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of osteodentin-like tissue. Altogether, these data suggest the regenerative potential of the 
hyaluronan-DPSC engineered tissue. 
Keywords: hyaluronan; stem cells; human dental pulp stem cells (DPSCs); dental pulp; 
tissue engineering; regenerative endodontics 
 
1. Introduction 
Dental pulp is a loose connective tissue in the central cavity of each tooth composed of four layers 
of cells: the external odontoblastic layer, the cell-free zone, the cell-rich zone and the internal parietal 
plexus of nerves. Deep inside, there is a great amount of fibroblasts and extracellular matrix (ECM). 
Other cells in the pulp include undifferentiated mesenchymal cells, fibrocytes, macrophages and 
lymphocytes. Dental pulp also contains blood vessels and nerves, which enter in the pulp cavity 
through the apical foramen [1]. 
The primary function of dental pulp tissue is to maintain the vitality of the tooth and to produce 
dentin. However, the pulp tissue is particularly vulnerable to external insult, because the small volume 
of tissue is contained in an unyielding dentin casing, its only available blood supply coming from one 
end, at the root apex [2]. 
Dental pulp disease typically progresses in several stages, described in various classifications as 
clinically normal pulp, pulpitis (which may or may not be reversible) and necrosis [3,4]. 
Directly capping dental pulp with various cement-based compounds containing hyaluronic acid  
(HA), calcium hydroxide or mineral trioxide aggregate, for instance, promotes dentinogenesis [5–8]. 
Cells remaining within the healthy portion of the pulp migrate to the injured site, proliferate in 
response to the growth factors released from the surrounding dentin matrix and become attached to the 
necrotic layer to form osteodentin. The cells attached to the osteodentin subsequently differentiate into 
odontoblasts, forming a reparative dentin that preserves the pulp’s integrity [9]. 
Dental pulp stem cells (DPSCs) play an important part in both oral and non-oral regenerative 
medicine because of their biological properties, which include multipotency, high proliferation rates 
and accessibility [10–13]. In addition, Karaöz et al. demonstrated that DPSCs are able to differentiate 
into both neural and vascular endothelial cells in vitro [14]. An ideal type of therapy might involve 
regenerative approaches in which diseased or necrotic pulp tissues are removed and replaced with 
regenerated pulp tissues to revitalize the teeth. In particular, regenerative pulp therapy would  
re-establish the normal tissue continuum at the pulp-dentin border by regulating the tissue-specific 
processes of reparative dentinogenesis [15,16]. One of the key aspects of this modern strategy 
concerns the use of biodegradable materials as scaffolds for the tridimensional (3D) growth of the cells 
previously expanded in vitro. The scaffolds provide a 3D environment for cells to attach and grow, 
therefore mimicking the in vivo condition. Apart from being biodegradable, an ideal scaffold should be 
biocompatible and have adequate physical and mechanical strength. Then, it should be porous to allow 
the placement of cells and effective transport of nutrients, oxygen, waste, as well as growth factors. 
Finally, it should be replaced by regenerative tissue, while retaining the shape and form of the final 
tissue structure [1]. Various natural and synthetic biomaterials have been investigated as scaffolds for  
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dental pulp tissue regeneration, such as ECM components, self-assembling systems, hydrogels or  
bioceramics [17–22]. 
A promising biomaterial in the field of tissue engineering and regenerative medicine is HA  
(also called hyaluronan) and its derivatives, obtained by HA esterification with different alcohols.  
The resulting hyaluronan-based biodegradable polymers have been used successfully with bone  
marrow- and adipose-derived mesenchymal stem cells in in vitro and in vivo studies [23–25] and  
in clinical applications [26,27]. Hyaluronan is a ubiquitous molecule of connective tissues. It has  
a fundamental role in many biological processes, such as water balance, cell recognition, embryonic 
development and wound healing, both in adult and fetal life stages. Compared to the above-mentioned 
materials, hyaluronan has more structural and physiological functions within tissues, including 
extracellular and cellular interactions, growth factor interaction and regulation of osmotic pressure  
and tissue lubrication, which help to maintain the structural and homeostatic integrity of tissues.  
Moreover, hyaluronan is quickly turned over in the body by hyaluronidase, with tissue half-lives 
ranging from hours to days [28]. 
Focusing on dentin-pulp complex regeneration, a hyaluronan-based scaffold can be projected to 
adapt easily to the variable shape of the pulp chamber, to have a relatively fast setting time and to 
prove amenable to root canal modeling and adaptation. The dental pulp tissue expresses hyaluronan  
in a different manner during tooth development; hyaluronan contributes to the development of the 
dentine matrix and dental pulp growth, but during odontogenesis, its expression gradually decreases 
with age [29]. The role of hyaluronan in preserving dental pulp vitality and inducing dentin repair has 
already been investigated. In vivo experiments suggest that hyaluronan alone or in combination with 
other biomaterials could provide a suitable environment for reparative dentin induction through 
mesenchymal stem cells differentiation [30–33]. 
In the present study, we propose a method for the in vitro reconstruction of a dental pulp-like tissue 
that combines the numerous properties of hyaluronan with the stemness of DPSCs. A population of 
DPSCs was isolated from third molars of healthy patients and seeded onto hyaluronan-based  
non-woven meshes in the presence of a sequential cocktail of differentiation factors, including 
neuronal, glial, endothelial and osteogenic factors. We have evaluated the in vitro neuronal, glial, 
endothelial and osteogenic commitment of DPSCs on 3D scaffolds by gene expression profiling and 
immunofluorescence (IF) analyses. Furthermore, we have filled the artificial construct in critical-size 
bone defects to assess the osteodentin-like tissue regeneration in vivo. 
2. Results and Discussion 
2.1. DPSC Isolation and Amplification 
An enriched population of DPSCs was isolated from third molars of healthy human subjects and 
expanded on tissue culture plates in the presence of basal medium. One day after seeding, the adherent 
DPSCs showed a round morphology and the ability to form colonies of different sizes (Figure 1a).  
After three days from seeding, the morphology of DPSCs was heterogeneous and varied among 
cuboidal and spindle-shaped (Figure 1b). After the first passaging step (Passage 1, p1), most cells 
appeared spindle-shaped, but cell colonies were still present (Figure 1c). After two passages (p2), 
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DPSCs acquired their final morphology: spindle-shaped and fibroblast-like (Figure 1d). Overall, the 
expanded DPSCs revealed a good proliferative potential and the ability to achieve confluence quickly. 
 
Figure 1. Morphological features of dental pulp stem cells (DPSCs). (a) One day after 
seeding; (b) After three days from seeding; (c) After the first passaging step; (d) DPSCs at 
Passage 2 (p2). 
2.2. In Vitro Construction of a Dental Pulp-Like Tissue 
In a previous study published by our group [34], the stemness of the isolated cells has been 
evaluated by analyzing their potential to differentiate into cells of mesodermal origin, like adipocytes, 
chondrocytes or osteocytes. When cultured in basal medium, DPSCs expressed the stem cell marker 
S100. On the contrary, in presence of differentiation media, the cells showed increased expression of 
the specific differentiation markers, such as osteocalcin, osteonectin, osteopontin and Von Willebrand 
factor, CD31 for osteogenic and endothelial commitment, respectively [34]. In addition, these cells 
have also been able to acquire a neuronal- or glial-like phenotype when properly stimulated. For 
example, the expression of beta-III tubulin was clearly detectable when DPSCs were cultured in 
neuronal differentiation medium, whereas the GFAP and CNPase mRNAs were found upregulated in 
the presence of glial differentiation medium [34]. 
Based on these interesting results, we proceeded with the development of a dental pulp-like tissue  
in vitro. As described above, dental pulp tissue contains different cell types: odontoblasts, endothelial 
cells, neurons and glial cells. In order to regenerate this complex structure, DPSCs were seeded onto 
hyaluronan-based scaffolds previously embedded with neuronal and glial factors, then cultivated with 
osteo-endothelial differentiation medium for 21 days. Hematoxylin/eosin (H/E) staining showed that 
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the cells were distributed both on the surface of the matrix and within the 3D construct. The DPSCs 
grew well inside the hyaluronan-based scaffold, filling all of the spaces between the fibers (Figure 2a). 
 
Figure 2. DPSCs seeded onto hyaluronan-based scaffolds and cultivated with 
differentiation medium for 21 days. (a) H/E staining; Fluorescence images of cells 
expressing (b) collagen type I (green), a component of the extracellular matrix (ECM);  
(c) Von Willebrand factor (red), an endothelial marker; (d) Beta-III Tubulin (red),  
a neuronal marker; and (e) GFAP (red), a glial marker. Cell nuclei and the biomaterial are 
stained blue. 
In order to assess the ECM production by DPSCs, IF staining of collagen type I, the major fibrous 
component of the dental pulp ECM, was performed. Positive staining for collagen type I (Figure 2b,  
in green) confirmed the ability of DPSCs to synthesize ECM components within hyaluronan fibers.  
After 21 days of 3D in vitro culture, the DPSCs showed the acquisition of endothelial, neuronal  
and glial phenotypes. Furthermore, in this case, the commitment and the 3D organization of the 
differentiated cells was evaluated by IF staining. The evidence of an endothelial phenotype was 
revealed by the presence of Von Willebrand factor (Figure 2c, in red), whereas neuronal and glial 
commitment was detected by the presence of beta-III tubulin and glial fibrillary acidic protein (GFAP) 
markers, respectively (Figure 2d,e, in red). In all figures, blue represents both cell nuclei and the 
hyaluronan-based biomaterial. 
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At the same time, gene expression analysis of multiple differentiation markers was performed.  
The expression of endothelial, osteo/odontogenic, neuronal and glial markers was evaluated after  
21 days in DPSCs seeded onto hyaluronan-based scaffolds in the presence of the differentiation 
medium with respect to the 3D constructs cultivated in basal medium. As shown in Figure 3, high 
levels of expression were detected for Von Willebrand factor (VWF) and platelet/endothelial cell 
adhesion molecule 1 (PECAM1), two markers specific of endothelial cells. Significant expression 
levels were also measured for the osteo/odontoblast-related markers, such as osteocalcin (OCN), 
osteonectin (ON), osteopontin (OPN), as well as for collagen type I (COL1A1). There was also 
specific expression of glial cell markers, such as GFAP and 2',3'-cyclic nucleotide 3' phosphodiesterase 
(CNP). Furthermore, the differentiated cells expressed nestin (NES) and tubulin beta 3 class III 
(TUBB3), which suggested a neurogenic potential of DPSCs. On the other hand, the low expression of 
the stem cell marker S100 calcium binding protein A4 (S100A4) confirmed the acquisition of a 
differentiated phenotype by DPSCs. 
 
Figure 3. Gene expression profile of endothelial markers (Von Willebrand factor (VWF), 
platelet/endothelial cell adhesion molecule 1 (PECAM1)), osteo/odontoblast-related 
markers (osteocalcin (OCN), osteonectin (ON), osteopontin (OPN), collagen type I 
(COL1A1)), glial cell markers (glial fibrillary acidic protein (GFAP), 2',3'-cyclic 
nucleotide 3' phosphodiesterase (CNP)), neuronal markers (nestin (NES), tubulin beta 3 
class III (TUBB3)) and stem cell marker S100A4 in DPSCs seeded onto hyaluronan-based 
scaffolds and cultivated with differentiation medium (black bars) or with basal medium 
(white bars) for 21 days. Significant differences between DPSCs in differentiation medium 
and DPSCs in basal medium (** p < 0.01; *** p < 0.001); R: relative expression. 
Taken together, these results seem to demonstrate that DPSCs were able to acquire all of the  
main phenotypes of the cells found in dental pulp tissue under specific culture conditions. These 
included the presence of the hyaluronan matrix treated with neural factors, as well as the addition of 
osteo-endothelial induction factors in the culture medium. 
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2.3. In Vivo Experiments 
In order to evaluate the bone regenerative properties of the hyaluronan-DPSCs construct, the dental 
pulp-like tissue obtained in vitro was used to repair a calvarial defect in the rat. Implanted hyaluronan 
scaffolds without cells were used as a control for assessing the influence of DPSCs in the process of 
bone regeneration in vivo. After one month, bone grafts were removed from the skull and used for 
histological and gene expression analyses. 
As shown by the Azan Mallory (Figure 4a) and Masson trichrome stainings (Figure 4b), the tissue 
showed several signs of regeneration. As the hyaluronan fibers (white and purple circles, respectively) 
degraded, blood vessels (red arrows) and a collagen matrix (yellow arrows) became apparent 
throughout the tissue at the site of the perforation. No inflammatory cells were visible inside or outside 
the tissue. The outer portions of the perforation site showed cellular proliferation, indicating the 
progression of tissue regeneration in this area. On the contrary, the Azan Mallory (Figure 4c) and 
Masson trichrome stainings (Figure 4d) of the hyaluronan scaffold without cells do not show the 
presence of blood vessels and ECM components around the hyaluronan fibers. This observation could 
be related to the regenerative capabilities of the implanted DPSCs. 
 
Figure 4. Cont. 
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Figure 4. Histological analyses of hyaluronan-DPSCs bone graft one month after rat 
calvarial defect repair. (a) Azan Mallory staining of collagen matrix (yellow arrow), blood 
vessels (red arrow) and hyaluronan fibers (white circles); (b) Masson’s trichrome staining 
of collagen matrix (yellow arrow), blood vessels (red arrow) and hyaluronan fibers (purple 
circles); (c) Azan Mallory and (d) Masson trichrome staining of hyaluronan bone graft 
without cells; and (e) Gene expression profile of dentin ECM-related markers (dentin 
sialophosphoprotein (DSPP), bone morphogenetic protein 2 (BMP2), BMP3), bone  
ECM-related markers (COL1A1, COL3A1, cathepsin B (CTSB), cathepsin D (CTSD)) and 
other bone markers (fibroblast growth factor 8 (FGF8), msh homeobox 1 (MSX1), tumor 
necrosis factor receptor superfamily (TNFRSF11A)) in the hyaluronan-DPSC bone graft 
(black bars) compared to the hyaluronan scaffold alone (white bars). Significant differences 
between hyaluronan-DPSCs bone graft and hyaluronan scaffold alone (** p < 0.01;  
*** p < 0.001); R: relative expression. 
In order to verify this hypothesis, the expression of dentin and osteoblast differentiation-related 
markers was evaluated in the transplanted tissues by real-time PCR (Figure 4e). Specific gene 
expression was identified for dentin ECM, growth factors and proteins related to bone ECM. In 
particular, high levels of genes related to dentin ECM, such as dentin sialophosphoprotein (DSPP), 
bone morphogenetic protein 2 (BMP2) and BMP3, were observed in the cell-based HA scaffolds 
compared to the empty biomaterials. Furthermore, mRNA coding for proteins related to bone ECM, 
such as COL1A1, collagen type III (COL3A1), cathepsin B (CTSB) and cathepsin D (CTSD), was 
significantly expressed. Other bone markers, such as msh homeobox 1 (MSX1), an osteoproliferative 
transcription factor, the tumor necrosis factor receptor superfamily (TNFRSF11A) and fibroblast 
growth factor 8 (FGF8), were found upregulated in test samples with respect to control samples. 
These results together demonstrate that the presence of DPSCs on the implanted scaffolds positively 
influenced the osteogenic regenerative process of the tissue. 
3. Experimental Section 
3.1. Biomaterial 
The biomaterial used in the present study was derived from the total esterification of HA  
(synthesized from 80 to 200 kDa sodium hyaluronate) with benzyl alcohol and named HYAFF-11™ 
Int. J. Mol. Sci. 2015, 16 4674 
 
 
(Fidia Advanced Biomaterials, Abano Terme, Padova, Italy). The end product is a non-crosslinked 
linear polymer of unknown molecular weight that is insoluble in aqueous solution, but hydrolyzes 
spontaneously over time, releasing benzyl alcohol and hyaluronan. 
HYAFF-11™ was used to create non-woven meshes (50 μm-thick fibers, specific weight of  
100 g/m2). The properties of these substrates are described in detail elsewhere [25]. 
3.2. DPSCs Isolation 
Human dental pulp samples were extracted from healthy third molars removed for orthodontic 
purposes from 18- to 35-year-old adults, after obtaining their informed consent. The Ethical 
Committee of Padua Hospital approved the research protocol. Before extraction, all individuals were 
checked for systemic and oral infections or diseases, and only disease-free subjects were selected for 
pulp collection. Each subject was pretreated for a week with professional dental hygiene. Before the 
extraction, the dental crown was coated with a 0.3% chlorhexidine gel (Forhans, New York, NY, 
USA) for 2 min. After mechanical fracturing, the dental pulp was harvested using a dental excavator or 
a Gracey curette. The pulp was gently removed and immersed for 1 h at 37 °C in a digestive solution 
containing 3 mg/mL collagenase type I from Clostridium histolyticum (Worthington Biochemical 
Corporation, Lakewood, NJ, USA) and 4 mg/mL Dispase II from Bacillus polymyxa (Roche Applied 
Science, Basel, Switzerland). After digestion, the solution was filtered through 70-µm Falcon strainers 
(BD Biosciences, Mississauga, ON, Canada). The cells were then cultured in basal medium made of 
Dulbecco’s Modified Eagle Medium (DMEM) (Lonza S.r.l., Milano, Italy) supplemented with 10% 
fetal bovine serum (FBS) (Bidachem S.p.A., Milano, Italy) and 1% penicillin/streptomycin (P/S) 
(EuroClone, Milan, Italy). 
3.3. Culture Media Preparation 
The neuronal differentiation medium consisted of NeuroBasal Medium (Gibco by Life 
Technologies, Paisley, UK) containing 1% FBS, 1% P/S, 2% b27 serum-free supplement (Gibco),  
10 µg/mL human recombinant beta nerve growth factor (bNGF) (ProSpec, East Brunswick, NJ, USA), 
100 ng/mL human recombinant brain-derived neurotrophic factor (BDNF) (ProSpec) and 20 ng/mL 
human recombinant neurotrophin-3 (NT3) (ProSpec). 
Glial differentiation medium was made of NeuroBasal Medium containing 1% FBS, 1% P/S, 1% 
N2 supplement (Gibco), 4 μM forskolin (Merck Millipore, Darmstadt, Germany) and 10 ng/mL human 
recombinant heregulin-β (ProSpec). 
Osteo-endothelial differentiation medium was made of basal medium supplemented with 10 mM  
β-glycerophosphate (Sigma-Aldrich, Saint Louis, MO, USA), 10 nM dexamethasone (Sigma-Aldrich), 
1 mg/mL heparin (Seromed, Berlin, Germany), 10 ng/mL platelet-derived endothelial cell growth  
factor (PD-ECGF) (Calbiochem, San Diego, CA, USA) and 10 ng/mL basic fibroblast growth factor 
(bFGF) (ProSpec). 
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3.4. DPSCs Differentiation in 3D 
Before seeding the cells, squares (1 cm × 1 cm) of non-woven meshes were cut and laid down on  
a 24-well culture plate using sterile forceps and scissors. The biomaterial was then embedded with 
both neuronal and glial differentiation media for 24 h at 37 °C in a humidified chamber containing 5% 
CO2. After completing this process, the non-woven squares were dehydrated under sterile conditions, 
and DPSCs were seeded at a density of 5 × 105 cells/cm2 in the presence of osteo-endothelial 
differentiation medium for 21 days. 
3.5. In Vitro Staining 
The 3D scaffolds loaded with DPSCs were embedded in an OCT compound (Bio-Optica, Milan, 
Italy) and then cut into 7 μm thick-sections with cryostat (Leica CM1950, Leica, Milano, Italy).  
The frozen sections were placed onto positive-charged slides and then fixed in 4% paraformaldehyde 
solution in PBS for 10 min. 
For H/E staining, the sections were stained with the nuclear dye, hematoxylin (Sigma-Aldrich), and 
the counterstain, eosin (Sigma-Aldrich). 
For IF staining, the sections were incubated in 2% bovine serum albumin (BSA, Sigma-Aldrich) 
solution in PBS for 30 min at room temperature. The sections were then incubated with the  
primary antibodies in 2% BSA solution in a humidified chamber overnight at 4 °C. The following 
primary antibodies were used: rabbit polyclonal anti-human Von Willebrand factor antibody 1:100 
(A0082; Dako, Milan, Italy); rabbit polyclonal anti-GFAP antibody 1:100 (AB5804; Millipore 
Corporation, Danvers, MA, USA); mouse monoclonal anti-collagen type I 1:100 (C2456; Sigma-Aldrich); 
chicken polyclonal anti-beta III tubulin antibody 1:100 (AB9354; Millipore Corporation). IF staining 
was performed with secondary antibodies: anti-rabbit IgG (H + L), DyLight 549 labeled (KPL, 
Gaithersburg, MD, USA); anti-mouse IgG, DyLight 488 labeled (KPL); or anti-chicken IgG (H + L), 
DyLight 549 labeled (KPL), diluted 1:1000 in 2% BSA for 1 h at room temperature. Nuclear staining 
was performed with 2 µg/mL Hoechst H33342 (Sigma-Aldrich) solution for 5 min. The sections were 
coverslipped with a drop of mounting medium. 
3.6. Real-Time PCR 
Total RNA was extracted with the RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany), including 
DNase digestion with the RNase-Free DNase Set (Qiagen). The RNA quality and concentration of the 
samples were measured using the NanoDrop™ ND-1000 (Thermo Scientific, Waltham, MA, USA). 
For the first-strand cDNA synthesis, 1000 ng of total RNA of each sample were reverse  
transcribed with M-MLV Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA), following the 
manufacturer’s protocol. 
Human and rat primers were selected for each target gene with Primer 3 software (Tables 1 and 2). 
Real-time PCRs were carried out using the designed primers at a concentration of 300 nM and 
FastStart SYBR Green Master (Roche Diagnostics, Mannheim, Germany) on a Rotor-Gene 3000 
(Corbett Research, Sydney, Australia). Thermal cycling conditions were as follows: 15 min 
denaturation at 95 °C; followed by 40 cycles of denaturation for 15 s at 95 °C; annealing for 30 s at 60 °C; 
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and elongation for 20 s at 72 °C. Differences in gene expression were evaluated by the 2∆∆Ct  
method [35]. For in vitro experiments, DPSCs cultured for 21 days on the 3D scaffold in basal medium 
were used as control condition. For in vivo experiments, bone grafts derived from the hyaluronan 
scaffold alone were considered the control condition. In both cases, values were normalized to the 
expression of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) internal reference, whose 
abundance did not change under our experimental conditions. 
Table 1. Human primer sequences. 
Gene 
Symbol 
Forward Primer (5'→3') Reverse Primer (5'→3') Product 
Length (bp) 
CNP AACCTTCCTGTCTTCATCCTTAGC ATCACAAGCCAACACACTCATTG 137 
COL1A1 TGAGCCAGCAGATCGAGA ACCAGTCTCCATGTTGCAGA 178 
GAPDH TCAACAGCGACACCCAC GGGTCTCTCTCTTCCTCTTGTG 203 
GFAP AGGAAGATTGAGTCGCTGGAG CGCCATTGCCTCATACTGC 177 
NES TCAGAGGGAAGGAGATAGAGAGTC AGCCAGAAACCATATGTCAAGAGA 171 
OCN GCAGCGAGGTAGTGAAGAGAC AGCAGAGCGACACCCTA 193 
ON TGCATGTGTCTTAGTCTTAGTCACC GCTAACTTAGTGCTTACAGGAACCA 183 
OPN TGGAAAGCGAGGAGTTGAATGG GCTCATTGCTCTCATCATTGGC 192 
PECAM1 TCCAGCCAACTTCACCATCC TGGGAGAGCATTTCACATACGA 171 
S100A4 AGGGTGACAAGTTCAAGCTCAA GCAGGACAGGAAGACACAGTA 176 
TUBB3 GCTCTACGACATCTGCTTCCG GAAGGGCACCATGTTGACG 163 
VWF ACGTATGGTCTGTGTGGGATC GACAAGACACTGCTCCTCCA 159 
CNP, 2',3'-cyclic nucleotide 3' phosphodiesterase; COL1A1, collagen, type I, alpha 1; GAPDH,  
glyceraldehyde-3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein; NES, nestin; OCN, 
osteocalcin; ON, osteonectin; OPN, osteopontin; PECAM1, platelet/endothelial cell adhesion molecule 1; 
S100A4, S100 calcium binding protein A4; TUBB3, tubulin, beta 3 class III; VWF, von Willebrand factor. 
Table 2. Rat primer sequences. 
Gene Symbol Forward Primer (5'→3') Reverse Primer (5'→3') Product 
Length (bp) 
BMP2 TGCTCAGCTTCCATCACG TTCCTGCATTTGTTCCCGAA 152 
BMP3 GATAGCCACGTCAGAGAAGC GCTTTCTCTCCTCCCACACTC 139 
COL1A1 AAAGATGGCGAAGCTGGAG GAAACCTCTCTCGCCTCTTG 210 
COL3A1 AATGGTGACAGAGGAGAAACG CCTCGATGTCCTTTGATGCC 149 
CTSB TGTGGAGGTGTCTGCTGAG GGAGGGATGGTGTAGGGTA 168 
CTSD GTCGGTTCCATGTAAGTCAGA ACTTGGCTGCGATGAATACG 101 
DSPP AGCAGGCAACATCACAACC TGACAGAGTAGATGAGTGGAGTG 122 
FGF8 CATGGCAGAAGACGGAGAC CCTTTGCCGTTGCTCTTGG 147 
GAPDH GGCCTTCCGTGTTCCTA AAGGTGGAAGAATGGGAGTTG 192 
MSX1 GGGATGCAAAGGCGAAGA GCTTTCTATAGGGCTGGGCTC 186 
TNFRSF11A CAACTCAACGGATGGCTACA TGGCTGCTGCTTCACTG 134 
BMP2, bone morphogenetic protein 2; BMP3, bone morphogenetic protein 3; COL1A1, collagen, type I, alpha 1; 
COL3A1, collagen, type III, alpha 1; CTSB, cathepsin B; CTSD, cathepsin D; DSPP, dentin sialophosphoprotein; 
FGF8, fibroblast growth factor 8; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MSX1, msh 
homeobox 1; TNFRSF11A, tumor necrosis factor receptor superfamily, member 11a, NF-κB activator. 
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3.7. In Vivo Experiments 
The bone regenerative properties of hyaluronan-DPSCs constructs were evaluated by calvarial 
implantation in 8-week-old female nude rats (n = 3) (Wistar-NIH-FOXN1, Charles River). Two critical 
defects were generated for each rat’s skull: one was filled with hyaluronan scaffolds alone (control 
samples) and the other with hyaluronan-DPSCs construct (test samples). Test samples were prepared 
as those for the in vitro experiments and maintained in culture for 7 days before being implanted. 
All surgical procedures were performed under general anesthesia with intraperitoneal injections of 
ketamine hydrochloride (Ketaras, Yuhan Corp., Seoul, Korea, 40 mg/kg) and xylazine (Rumpens 
Bayer Korea Ltd., Seoul, Korea, 10 mg/kg). The calvarial skin was disinfected with 10% betadine 
(Potadines, Sam-II Pharm., Seoul, Korea); then, 2% lidocaine containing 1:100,000 epinephrine 
(Lidocaine HCL, Epinephrine Inj., Yuhan Corp., Korea) was subcutaneously injected into the calvarial 
bone. At this point, an incision was made along the sagittal suture. The periosteum was raised, and a 
calvarial bone defect 5 mm in diameter was created using a trephine burr without perforating the dura. 
The area of the defect was filled with either the control or the test samples. All animals were treated 
and handled in accordance with the “Recommendations for Handling Laboratory Animals for 
Biomedical Research” compiled by the Committee on the Safe and Ethical Handling Regulations for 
Laboratory Experiments at the University of Padova, Padova, Italy. The animals were housed separately 
in temperature-controlled cages (22 °C) with a 12-h day/night cycle and were unrestrained, with food 
available “ad libitum”. 
After 1 month, the animals were sacrificed under formalin perfusion, and the calvarial bone was 
removed from the skull. 
For histological analyses, the calvarial bone was fixed in 4% paraformaldehyde solution in PBS 
overnight, decalcified with 10% EDTA (Sigma-Aldrich), pH 7.2, then paraffin-embedded and cut into  
7 μm-thick sections. The bone graft sections were stained with Azan Mallory (Bio-Optica) or with 
Masson trichrome (Sigma-Aldrich). 
For gene expression analyses, bone grafts were processed as described above (Section 3.6.). 
3.8. Statistical Analysis 
One-way analysis of variance (ANOVA) was used to analyze the data. 
Levene’s test was used to demonstrate the equal variances of the variables. Repeated measures 
analysis of variance (Re-ANOVA), with a post hoc analysis using Bonferroni’s multiple comparison 
test, was used to identify any significant changes (p < 0.05). * p < 0.05; ** p < 0.01; *** p < 0.001. 
Repeatability was calculated as the standard deviation of the difference between measurements.  
All tests were performed using the SPSS 16.0 software package (SPSS Inc., Chicago, IL, USA)  
(licensed to the University of Padova, Italy). 
4. Conclusions 
The dental pulp is a complex tissue, which includes different specialized cells, blood vessels and 
nerves. In the present study, we propose a method for the in vitro reconstruction of a dental pulp-like 
tissue using a hyaluronan matrix as the scaffold for the 3D differentiation of DPSCs towards neuronal, 
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glial, endothelial and osteogenic phenotypes. Hyaluronan was chosen because it is a molecule of ECM 
that is distributed ubiquitously. Moreover, it is a biodegradable polymer that can be projected to adapt 
easily to the variable shape of the pulp chamber. On the other hand, DPSCs, the source of stem cells 
within the dental pulp, can differentiate into several cell lineages under defined conditions. In the  
present work, a population of DPSCs was seeded onto hyaluronan-based scaffolds in the presence of a 
sequential cocktail of differentiation factors, including neuronal, glial, endothelial and osteogenic 
factors. Gene expression profiling and immunofluorescence analyses confirmed the neuronal, glial, 
endothelial and osteogenic commitment of DPSCs on 3D scaffolds in vitro. Furthermore, the in vivo 
engraftment of hyaluronan scaffolds seeded with DPSCs in critical-size bone defects in rats confirmed 
the osteo-regenerative properties of these constructs. 
In conclusion, these data demonstrate that the combination of a hyaluronan-based biomaterial and 
DPSCs could be a good strategy to generate a dental pulp-like tissue having the ability to repair a 
calvarial defect in an in vivo rat model. 
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